HomeOpen Access NewsHealthcare Innovation

Healthcare Innovation

UHCW to lead trial of new device to address miscarriage symptoms

University Hospitals Coventry and Warwickshire (UHCW) NHS Trust is to lead a clinical trial of a novel device aimed at addressing miscarriage symptoms.

Improving cancer treatment and services during and beyond COVID-19

Greg Quinn, BD UK, explores how cancer treatment and services have been impacted by the pandemic and the potential role of medical technology in supporting the NHS during this complex time.

Survey finds 30% of people with PCOS rely on online forums for information

There is little mainstream awareness of the condition that impacts one in ten women - currently, 30% of people with Polycystic ovary syndrome (PCOS) rely on online forums for information.

HealthTracker™ for patients, clinician & researchers

Professor Paramala Santosh, CEO of HealthTracker Ltd, co-developed the HealthTrackerTM platform – developed by clinicians, assisted by patients for patients, clinicians & researchers, more of which we learn about here.

Johnson & Johnson factory accident damages 15 million vaccine doses

A "human error" created a factory mixup for Johnson & Johnson in Baltimore, Maryland, damaging up to 15 million vaccine doses - but this does not impact doses that are ready for use.

UK cancer research sector could lose 20% of funding after Horizon Europe

The Institute of Cancer Research found that UK cancer research sector could lose up to 20% of their funding, after UKRI replaces Horizon Europe.

How can touch-free technology help the NHS?

Here, Videx UK highlights how innovative hands-free door entry can help services return to normalcy post-COVID-19.

Moderna and Pfizer vaccines 90% effective in US real-world data

Real-world use of the Moderna and Pfizer vaccines in the United States reveals that both are working at 90% efficacy - with data pointing to one dose being capable of 80% protection.

A healthcare system for the 21st century

Ben Howlett, Managing Director at Public Policy Projects, discusses why we must invest in technology to enable our healthcare systems to reform, and the role of technology in facilitating collaboration between service providers.

Data finds 36% of people refuse COVID vaccine due to side effect fears

According to new ONS data, 36% of UK people who are vaccine hesitant have strong side effect fears - while a further 12% fear needles, and 22% think vaccines could impact fertility.

Zebra Technologies: Dedicated to improving global health

We spoke with Tony Cecchin, Vice President and General Manager of Global Supplies at Zebra Technologies and President of Temptime Corporation, and Chris Caulfield, Vice President of Temptime Operations about their work supporting front-line workers and easing the shipment of medical products through the supply chain.

Curative approach to severe autoimmune diseases

Andrew Mackie, VP Business Development tells us how Imcyse, a Belgian immunotherapy expert, seeks a curative approach to severe autoimmune diseases.

Reconstructive Dentistry: New biomaterials & technologies

Mutlu Özcan, Prof. Dr Dr h.c., PhD from the University of Zürich, highlights Reconstructive Dentistry through new biomaterials and technologies, including the associated changes and challenges.

AstraZeneca vaccines made for UK could be kept for EU use only

EU leaders today (25 March) decided not to create an export ban for AstraZeneca vaccines made for the UK - but the feud between AstraZeneca and the bloc remains close to the surface of future discussions.

Scientists reveal that tinnitus is possible COVID-19 symptom  

The University of Manchester found that tinnitus could be a COVID-19 symptom - some patients of the virus are reporting a loss in hearing and ringing of the ears.

Dexamethasone steroid saved one million people from COVID death

The Dexamethasone steroid has been used across the globe to help treat COVID-19 in the ICU - leading to atleast one million survivors of hospitalisation from the virus.

US trial finds AstraZeneca vaccine 100% effective against COVID death

In a study of over 32,000 people, a US trial found the AstraZeneca vaccine was 100% effective against deaths caused by COVID-19 - the vaccine did not show any connection to blood clots.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders